GlobalData on MSN
The innovators working to make in vivo cell therapy a reality
As in vivo cell therapies enter clinical trials, suppliers tackle the technical and logistical barriers to commercial viability.
Speaking at the ELRIG meeting at Hinxton Hall in March, Dr Seng H. Cheng set out how next-generation adeno-associated viral vector engineering has begun to move gene therapy beyond early ...
A routine inspection into Afbi’s operations identified biosecurity shortcomings ...
Claude research suggests functional emotions shape AI behavior, without proving subjective feelings or consciousness.
Professor Eric Alton outlined how a 25-year UK collaboration has pushed respiratory gene therapy from concept towards the ...
UF scientist develops safer gene therapy restoring vision in children with rare inherited eye diseases; pivotal trials begin ...
How mature is your AI agent security? VentureBeat's survey of 108 enterprises maps the gap between monitoring and isolation — ...
Karpathy proposes something simpler and more loosely, messily elegant than the typical enterprise solution of a vector ...
New vulnerabilities in Apache Traffic Server highlight the growing security burden facing critical open-source infrastructure ...
As the joke goes, CRQC has been 10 to 20 years away for the past three decades. While the recent research suggests that ...
A handful of AI infrastructure startups are doing complex, rarely-seen work that makes it possible for the U.S. government to ...
The astronauts are on their way to space, even after NASA identified two issues that could have halted the mission. Stay with us for all the latest.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results